pharma · Asthma · Osteoarthritis · AMRX
Amneal Pharma Europe
Amneal Pharma Europe Ltd
Amneal Pharma Europe trial registry — 17 ClinicalTrials.gov studies with program phase, status, and indication context.
400 Crossing Boulevard, Bridgewater, New Jersey 08807, US HQ
2002 Founded
7,179 Employees
Public company Type
AMRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- 400 Crossing Boulevard, Bridgewater, New Jersey 08807, US
- Founded
- 2002
- Employees
- 7,179
- Programs
- 15
- Drugs
- 210
- Patents
- 32
Amneal Pharma Europe clinical trials
Registry index of 17 ClinicalTrials.gov studies linked to Amneal Pharma Europe programs — each row shows trial ID, program name, phase, status, and indication.
Amneal Pharma Europe trial registry — 17 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Amneal Pharma Europe.
-
AM-PHN-004 — Phase 3
Clinical update -
Test - Bimatoprost 0.01% Ophthalmic Solution — Phase 3
Clinical update -
Phenazopyridine Hydrochloride — Phase 3
Clinical update -
Mometasone Furoate Nasal Spray, 50 mcg — Phase 3
Clinical update -
Imatinib Mesylate Tablets, 400 mg — Phase 3
Clinical update -
Estradiol Vaginal Tablets 10 mcg — Phase 3
Clinical update -
CREXONT ER — Approved
Clinical update -
Bimatoprost Ophthalmic Solution, 0.01% — Phase 1
Clinical update